Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.
Eligibility criteria
Qualifiers
Any patient >= 18 years of age
Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies
Disqualifiers
Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov